,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['bcsm', 'destiny-04']
it s here!!! it s here!!! check out this landmark interview between and about the destiny-04 trial! #bcsm #obroncology #asco22 
Executive Managing Editor of #OBROncology (https://t.co/XW1VL90pYg) and #PatientPower (https://t.co/WHsQe8gmv5) at Remedy Health Media. Opinions are mine.